| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200001133420203 |
| P698 | PubMed publication ID | 10631276 |
| P50 | author | Doris L. Wethers | Q19594759 |
| Lynn A Sleeper | Q63826336 | ||
| P2093 | author name string | Smith J | |
| Weiner SJ | |||
| Kinney TR | |||
| Wang WC | |||
| Pegelow CH | |||
| Miller ST | |||
| Enos LE | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sickle-cell disease | Q185034 |
| P304 | page(s) | 83-89 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Prediction of adverse outcomes in children with sickle cell disease. | |
| P478 | volume | 342 |
| Q36007731 | A network model to predict the risk of death in sickle cell disease |
| Q38861043 | A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria |
| Q34038874 | A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis |
| Q36286034 | Abnormal transcranial Döppler ultrasonography in children with sickle cell disease |
| Q40553853 | Acute Chest Syndrome: the role of erythro-exchange in patients with sickle cell disease in Sicily |
| Q35017415 | Acute chest syndrome in severity of sickle cell diseases |
| Q38866086 | Acute painful crises of sickle cell disease in Egyptian children: predictors of severity for a preventive strategy |
| Q37969631 | Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. |
| Q47614537 | Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia |
| Q48506010 | Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial |
| Q35780522 | Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda |
| Q52030668 | An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. |
| Q37413923 | An observational study of children with sickle cell disease in Kilifi, Kenya |
| Q35170873 | Anaesthetic management of the child with sickle cell disease |
| Q37346672 | Asthma management in sickle cell disease |
| Q44707850 | Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma |
| Q35087447 | Autonomic nervous system reactivity: children with and without sickle cell disease |
| Q46480574 | Autonomic reactivity and clinical severity in children with sickle cell disease |
| Q40205269 | Autosplenectomy in severity of sickle cell diseases |
| Q39992806 | Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents |
| Q55427971 | Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. |
| Q88736275 | Biomarker signatures of sickle cell disease severity |
| Q37961814 | Biomarkers in sickle cell disease |
| Q33789007 | Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial |
| Q47936167 | Brain morphometric analysis predicts decline of intelligence quotient in children with sickle cell disease: A preliminary study |
| Q37128824 | C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet |
| Q89183960 | CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease |
| Q55262636 | Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth. |
| Q36392798 | Cerebrovascular disease associated with sickle cell pulmonary hypertension |
| Q39197534 | Characteristics of sickle cell anemia in Yemen |
| Q40147937 | Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study. |
| Q34800466 | Clinical biomarkers in sickle cell disease |
| Q39002825 | Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa. |
| Q39195134 | Clinical profile of sickle cell disease in Yemeni children |
| Q44992413 | Coinheritance of α-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia |
| Q48312367 | Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia |
| Q37096984 | Cord blood stem cell transplantation for haemoglobinopathies |
| Q35552533 | Cytokines in sickle cell disease |
| Q36633685 | Dactylitis, a term for different digit diseases |
| Q36594215 | Dactylitis: pathogenesis and clinical considerations |
| Q52945139 | Decreased morbidity in homozygous sickle cell disease detected at birth. |
| Q24194549 | Deferasirox for managing transfusional iron overload in people with sickle cell disease |
| Q24236463 | Deferasirox for managing transfusional iron overload in people with sickle cell disease |
| Q24242535 | Deferasirox for managing transfusional iron overload in people with sickle cell disease |
| Q36065185 | Defining stroke risk in children with sickle cell anaemia |
| Q44949708 | Development and validation of a pediatric severity index for sickle cell patients |
| Q42476322 | Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin. |
| Q41965362 | Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with sickle cell disease. |
| Q38804432 | Emerging point-of-care technologies for sickle cell disease screening and monitoring. |
| Q30481575 | Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. |
| Q47310156 | Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice |
| Q46520558 | Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience. |
| Q35204817 | Erythrocyte indices in Pre-school Nigerian Children with Sickle Cell Anaemia in Steady State |
| Q33856205 | Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia |
| Q26744706 | Evolving locally appropriate models of care for indian sickle cell disease |
| Q35098084 | Exciting new treatment approaches for pathyphysiologic mechanisms of sickle cell disease |
| Q42195543 | First presentation of sickle cell anemia in a 3.5-year-old girl: a case report |
| Q34396393 | Follow-up of children with hemoglobinopathies diagnosed by the Brazilian Neonatal Screening Program in the State of Pernambuco |
| Q35204794 | GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study |
| Q40159032 | Gender differences in severity of sickle cell diseases in non-smokers. |
| Q36155283 | Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia |
| Q35848010 | Genetic influences on peripheral blood cell counts: a study in baboons. |
| Q43461620 | Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes |
| Q90385056 | Genetic variants of GCH1 associate with chronic and acute crisis pain in African Americans with sickle cell disease |
| Q35278672 | Glomerular hyperfiltration and albuminuria in children with sickle cell anemia |
| Q37354296 | Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? |
| Q43723150 | Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease. |
| Q34360069 | Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria |
| Q35594060 | Haematopoietic cell transplantation in the treatment of sickle cell disease |
| Q38851953 | Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches |
| Q36912757 | Has stem cell transplantation come of age in the treatment of sickle cell disease? |
| Q36882504 | Headache in children with sickle cell disease: prevalence and associated factors |
| Q36717337 | Hematopoietic cell transplantation for sickle cell disease: state of the art. |
| Q35158960 | Hematopoietic stem cell transplantation in sickle cell disease |
| Q26800236 | Hematopoietic stem cell transplantation in sickle cell disease: patient selection and special considerations |
| Q35923578 | Hereditary haemolytic anaemias: unexpected sequelae of mutations in the genes for erythroid membrane skeletal proteins |
| Q36868781 | Histopathology of experimentally induced asthma in a murine model of sickle cell disease |
| Q50733315 | Homozygous sickle cell disease in patients above 20 years of age: follow-up of 108 patients in Dakar |
| Q33985120 | How I use hydroxyurea to treat young patients with sickle cell anemia |
| Q42064984 | How to reach rapid diagnosis in sickle cell disease? |
| Q35097294 | Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). |
| Q56787000 | Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients |
| Q34086763 | Hydroxyurea and growth in young children with sickle cell disease |
| Q61908540 | Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa |
| Q36612962 | Hydroxyurea for children with sickle cell disease |
| Q40721306 | Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines |
| Q53236896 | Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. |
| Q33886125 | Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. |
| Q34947693 | Increased reticulocytosis during infancy is associated with increased hospitalizations in sickle cell anemia patients during the first three years of life |
| Q35914597 | Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study |
| Q37406275 | Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease |
| Q42484224 | Inhibition of phosphodiesterase 9A reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals. |
| Q36150411 | Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial. |
| Q39156028 | Intravascular hemolysis and the pathophysiology of sickle cell disease |
| Q51019805 | Lactate dehydrogenase and severity of pain in children with sickle cell disease. |
| Q37810108 | Leukotriene pathway in sickle cell disease: a potential target for directed therapy |
| Q37262682 | Longitudinal decline in lung volume in a population of children with sickle cell disease. |
| Q30833776 | Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli |
| Q33904379 | Management of cerebral vasculopathy in children with sickle cell anaemia |
| Q35611782 | Management of sickle cell disease in primary care |
| Q35582684 | Managing sickle cell disease |
| Q35672817 | Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia |
| Q46150811 | Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infection |
| Q90029424 | Measuring success: utility of biomarkers in sickle cell disease clinical trials and care |
| Q36913577 | Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication |
| Q37107206 | Minireview: Prognostic factors and the response to hydroxurea treatment in sickle cell disease |
| Q51545644 | Molecular characterization of sickle cell anemia in the Northern Brazilian state of Pará |
| Q33379114 | Morphological and functional platelet abnormalities in Berkeley sickle cell mice |
| Q35898039 | Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India |
| Q40427449 | Neurocognitive sequelae of sickle cell disease: current issues and future directions |
| Q37812519 | Neuroimaging in assessment of risk of stroke in children with sickle cell disease |
| Q34941213 | Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion |
| Q48690055 | Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease |
| Q57281769 | Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia |
| Q36830328 | Outcome and challenges of kidney transplant in patients with sickle cell disease |
| Q37423399 | Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease |
| Q35567943 | Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy |
| Q57452740 | Pathophysiology of Sickle Cell Disease |
| Q34703702 | Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations |
| Q44417162 | Placenta growth factor activates monocytes and correlates with sickle cell disease severity |
| Q37082000 | Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease |
| Q37019811 | Placental growth factor attenuates suppression of erythroid colony formation by interferon |
| Q30640505 | Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population). |
| Q51370434 | Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. |
| Q36384757 | Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. |
| Q37504884 | Predictors of outcome following acquired brain injury in children |
| Q89777671 | Primum non nocere: the case against transplant for children with sickle cell anemia without progressive end-organ disease |
| Q35615734 | Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. |
| Q33662087 | Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease |
| Q50738016 | Quantitative trait loci for baseline erythroid traits. |
| Q40376064 | Quantitative trait loci for baseline white blood cell count, platelet count, and mean platelet volume. |
| Q52727244 | Renal protection by atorvastatin in a murine model of sickle cell nephropathy. |
| Q34052855 | Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease |
| Q36034663 | Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. |
| Q35069324 | Salmonella osteomyelitis of the hand in an infant with sickle cell disease |
| Q61961373 | Seizures in the Jamaica cohort study of sickle cell disease |
| Q64951166 | Serum homocysteine and disease severity in sickle cell anemia patients in Lagos. |
| Q55298099 | Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes. |
| Q37612447 | Severe sickle cell disease--pathophysiology and therapy |
| Q35127288 | Sickle cell anemia as an inflammatory disease |
| Q46127056 | Sickle cell anemia from central India: a retrospective analysis |
| Q39737459 | Sickle cell anemia in Brazil: personal, medical and endodontic patterns. |
| Q50324935 | Sickle cell anemia: experience in a center |
| Q37650483 | Sickle cell disease at the dawn of the molecular era. |
| Q27303155 | Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease. |
| Q27693325 | Sickle cell disease in childhood: from newborn screening through transition to adult medical care |
| Q26864582 | Sickle cell disease in children |
| Q51126774 | Sickle cell disease in children: chronic complications and search of predictive factors for adverse outcomes. |
| Q52354763 | Sickle cell disease. |
| Q35723452 | Sickle cell disease: old discoveries, new concepts, and future promise |
| Q53170442 | Sickle cell disease: the Lebanese experience. |
| Q34733113 | Sickle cell disease: the neurological complications |
| Q34415126 | Sickle cell diseases and ileus. |
| Q36036759 | Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities |
| Q28287003 | Sickle-cell disease |
| Q31152018 | Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain |
| Q37476378 | Silent infarcts in young children with sickle cell disease |
| Q46987699 | Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease |
| Q44325054 | Steady-state sVCAM-1 serum levels in adults with sickle cell disease |
| Q35098099 | Stem cell transplantation for sickle cell disease: can we reduce the toxicity? |
| Q38028432 | Stem cell transplantation for treatment of sickle cell disease: bone marrow versus cord blood transplants |
| Q53636732 | Stroke in Children with Sickle Cell Disease. |
| Q64290214 | The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells |
| Q46073592 | The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease |
| Q38176054 | The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease |
| Q33825794 | The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival |
| Q91952781 | The genetics of human hematopoiesis and its disruption in disease |
| Q36685876 | The mouse as a model for human biology: a resource guide for complex trait analysis |
| Q37201472 | The natural history of sickle cell disease |
| Q37811628 | The paradox of the neutrophil's role in tissue injury |
| Q36627220 | The prevention and management of stroke in sickle cell anaemia |
| Q35571071 | The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease. |
| Q39221792 | The role of suggestions and personality characteristics in producing illness reports and desires for suing the responsible party |
| Q47358564 | The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study. |
| Q35644219 | Tonsilectomy in sickle cell diseases. |
| Q35534184 | Wasting as an independent predictor of mortality in patients with cystic fibrosis |
Search more.